We take a look at a trust which could add significant diversification to income investors’ portfolios…
By Marek Poszepczynski and Ailsa Craig, co-investment managers of the International Biotechnology Trust...
After a vintage year in which healthcare stocks were at the forefront of addressing the coronavirus pandemic, a wave of M&A in the sector promises opportunities for investors…
Download the presentation and listen to the audio from our 'Ideas for your ISA' Spring Conference on 03 March...
This trust offers a blend of characteristics which might appeal to many investors...
The acquisition of smaller biotech companies by their larger counterparts has been a tailwind for investors in this high-octane sector...
We meet the team of doctors and medical scientists behind International Biotechnology Trust...
IBT offers a differentiated exposure to a secular growth theme complemented by a solid yield…
International Biotechnology Trust (IBT) released its interim results this week, amid a rapidly changing landscape for the healthcare sector...
At a time when healthcare is in the headlines, we take a look at the longer-term trends that are driving biotechnology innovation on a global scale...
We discuss the opportunity as biotech stocks trade at record low valuations, despite strong prospects for the sector...
Chairman of International Biotechnology Trust, John Aston, explains how his unusual background in both biotechnology and banking come together on the trust...